MAM
ANIK icon

Meeder Asset Management’s Anika Therapeutics ANIK Stock Holding History

Meeder Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.5K Buy
+2,496
New +$37K ﹤0.01% 514
2022
Q4 		– Sell
-351
Closed -$8K – 846
2022
Q3 		$8K Buy
351
+293
+505% +$6.74K ﹤0.01% 1387
2022
Q2 		$1K Buy
58
+19
+49% +$424 ﹤0.01% 1972
2022
Q1 		$1K Buy
+39
New +$1.19K ﹤0.01% 2135
2021
Q4 		– Sell
-18
Closed -$1K – 1188
2021
Q3 		$1K Hold
18
– – ﹤0.01% 2274
2021
Q2 		$1K Sell
18
-27
-60% -$1.15K ﹤0.01% 2301
2021
Q1 		$2K Buy
45
+27
+150% +$1.02K ﹤0.01% 2053
2020
Q4 		$1K Sell
18
-4
-18% -$152 ﹤0.01% 1586
2020
Q3 		$1K Buy
22
+11
+100% +$397 ﹤0.01% 1918
2020
Q2 		$0 Buy
+11
New +$362 ﹤0.01% 2036
2020
Q1 		– Sell
-474
Closed -$24K – 2314
2019
Q4 		$24K Sell
474
-1,257
-73% -$73K ﹤0.01% 1288
2019
Q3 		$94K Buy
+1,731
New +$88.9K 0.01% 825
2019
Q2 		– Sell
-43
Closed -$1K – 2024
2019
Q1 		$1K Buy
+43
New +$1.47K ﹤0.01% 1606

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Meeder Asset Management's ANIK Position: Q2 2026 in Review

Meeder Asset Management opened a new position in Anika Therapeutics (ANIK) in Q2 2026: 2,496 shares worth $36.5K. The stake represents ﹤0.01% of the portfolio and ranks #514 among its holdings. This is a return to the name: Meeder Asset Management previously reported a position in ANIK as recently as Q3 2022.

Meeder Asset Management first reported a position in ANIK in Q1 2019 and has held it in 13 quarters since. The position peaked at $94K in Q3 2019. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Meeder Asset Management held 2,496 shares of Anika Therapeutics worth $36.5K as of Q2 2026.
  • Anika Therapeutics was a new Meeder Asset Management position in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of Meeder Asset Management's portfolio in Q2 2026, its #514 holding.
  • Meeder Asset Management first reported a position in Anika Therapeutics in Q1 2019 and has held it in 13 quarters since.
  • Meeder Asset Management's Anika Therapeutics position peaked at $94K in Q3 2019.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.